Delivery Order V797D40089-36C26124F0283
- This contract was awarded to Biopool US, Inc., a foreign-owned, for-profit manufacturer and distributor of clinical laboratory diagnostics and testing equipment that does business as Trinity Biotech Distribution. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 on May 23, 2019 and has a potential value of $115,041.75. It is a BPA (Blanket Purchase Agreement) Call under the Critical Analyzers, Laboratory...
- This federal contract award was issued by the Department of Veterans Affairs to Biopool U.S., Inc., a subsidiary of Trinity Biotech PLC, for the provision of service lab reagents for glycohemoglobin testing. The contract, which has a ceiling value of $429,024.90, was awarded on a firm fixed price basis. It is a delivery order contract under the Critical Analyzers, Laboratory (FSS-66-III) master schedule. The contract does not have a set-aside designation. Through this award, Biopool U.S., Inc....
- The U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 17, has awarded a firm fixed price delivery order contract to Biopool U.S., Inc., a subsidiary of Trinity Biotech PLC, for the provision of glycated hemoglobin (HbA1c) testing equipment, supplies, and associated laboratory services. This $120,398.25 contract has a period of performance through July 31, 2024 and is not designated as a set-aside procurement. Biopool U.S., Inc. has previously held contracts with...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Biopool U.S., Inc., doing business as Trinity Biotech Distribution, for the provision of Hemoglobin A1C testing services at a cost per reportable result. The contract has a ceiling value of $34,000.00 and a period of performance from July 1, 2025 to June 30, 2026. Biopool U.S., Inc. is a foreign-owned, for-profit manufacturer of medical diagnostic products and laboratory...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 awarded a $100,932.15 firm fixed price definitive contract to Biopool US, Inc., doing business as Trinity Biotech Distribution, on October 1, 2018 to provide coagulation cost per test services. The contract has a completion date of September 30, 2023 and was awarded without a set-aside designation in response to a solicitation posted on August 20, 2018 seeking these products and services....
- Biopool U.S., Inc., doing business as Trinity Biotech Distribution, was awarded a delivery order valued at $114,181.35 by Veterans Integrated Service Network 17 (VISN 17), part of the Department of Veterans Affairs, on August 1, 2024. This firm fixed-price delivery order, designated CTX VA A1C CPRR IDIQ, is scheduled for completion by July 31, 2025, and was issued without set-aside designation, indicating full and open competition. The order will be performed in Jamestown, New York. This...
- This is a federal contract award to Biopool U.S., Inc., doing business as Trinity Biotech Distribution, for the provision of hemoglobin A1c testing services on a cost per reportable results (CPRR) basis. The contract, valued at a ceiling of $42,500.00, was awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA). The contract is a Blanket Purchase Agreement (BPA) call, issued under the VA's Critical Analyzers, Laboratory Federal Supply...
- This is a firm fixed price call order awarded by the U.S. Department of Veterans Affairs to Biopool U.S., Inc., a subsidiary of Trinity Biotech PLC, for glycated hemoglobin (HbA1c) clinical reference laboratory services. The call order has a ceiling value of $95,657.75 and an ultimate completion date of November 21, 2020. The contract was awarded without a set-aside on November 22, 2019 under the Critical Analyzers, Laboratory (FSS-66-III) GSA schedule. Biopool U.S., Inc. has provided various...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded to Biopool U.S., Inc., a subsidiary of Trinity Biotech PLC, by the Department of Veterans Affairs (VA). The contract is for the provision of Hemoglobin A1C testing services on a "Cost Per Reportable Results" basis, with a ceiling value of $36,771.85 and a period of performance ending on June 30, 2024. The contract is not set aside for any specific business type. Biopool U.S., Inc. is a foreign-owned,...
- Biopool U.S., Inc., doing business as Trinity Biotech Distribution, received a $6,394.64 firm fixed-price Purchase Order from the Department of Veterans Affairs' Veterans Integrated Service Network 21 for the "Ratification Test GHB Premier" contract. Awarded on January 1, 2024, with an ultimate completion date of December 3, 2025, this contract was not issued under a set-aside designation, indicating full and open competition. The place of performance is Reno, Nevada. Biopool U.S.,...
- Critical Analyzers, Laboratory (FSS-66-III)Master GSA Schedule
- V797D40089Federal Supply Schedule
- V797D40089-36C26124F0283Delivery Order
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Biopool US, Inc., a foreign-owned for-profit manufacturer and distributor of clinical laboratory diagnostics and testing equipment doing business as Trinity Biotech Distribution. The $22,230.00 contract is for the provision of glycohemoglobin analyzers, which are critical laboratory analyzers used to support quality healthcare and medical readiness programs. Biopool US, Inc. has a history of providing a variety of medical testing products and services to federal agencies, including the Departments of Veterans Affairs, Defense, Justice, and Air Force, through various contract vehicles such as indefinite delivery contracts and blanket purchase agreements. This award was not set aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.2k | 3/27/24 |